The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 31, 2019

Filed:

Jun. 06, 2016
Applicant:

Qaam Pharmaceuticals, Llc, Canandaigua, NY (US);

Inventors:

Steven A. Rich, Canandaigua, NY (US);

Emerich Eisenreich, Claremont, CA (US);

Xuejun Karl Liu, Arcadia, CA (US);

Bingidimi Itute Mobele, Altamont, NY (US);

Satish Goud Puppali, Rancho Cucamonga, CA (US);

Assignee:

QAAM PHARMACEUTICALS, LLC, Canandaigua, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 207/12 (2006.01); C07C 53/126 (2006.01); C07C 57/12 (2006.01); C07C 57/03 (2006.01);
U.S. Cl.
CPC ...
C07D 207/12 (2013.01); C07C 53/126 (2013.01); C07C 57/03 (2013.01); C07C 57/12 (2013.01);
Abstract

Novel glycopyrronium fatty acid salts have been developed. Bi-phasic reaction conditions enable the desired counterion exchange reactions between glycopyrronium bromide and fatty acid salts of alkali metals and alkaline earth metals in methods to form glycopyrronium fatty acid salts. In preferred embodiments, an excess of the free fatty acid in the reaction mixture stabilizes the glycopyrronium fatty acid salt and reduces the formation of the impurity, Acid A. In some preferred embodiments, between 0.2 and 1.2 molar equivalent of excess free fatty acid is added to the reaction mixture. In another embodiment, approximately 1.2 molar equivalent of excess free fatty acid is added to the reaction mixture.


Find Patent Forward Citations

Loading…